Evidence map›Paper›PMID 35110532›Full record

ArticleNature communications2022

Manipulation of RNA polymerase III by Herpes Simplex Virus-1.

Sarah E Dremel, Frances L Sivrich, Jessica M Tucker, Britt A Glaunsinger, Neal A DeLuca

Open access · goldAbstract read
In one paragraph

Article in Nature communications, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed
5.3field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed, 37 citations in OpenAlex.

  1. Review
  2. YBX1 regulates RNA polymerase III transcripts to prevent inflammation.Proceedings of the National Academy of Sciences of the United States of America · 2026
    Article
  3. Article
  4. tRNA modifications in viral replication.The Journal of biological chemistry · 2026
    Review
  5. Article
  6. Review
  7. Article
  8. Review
  9. Article
  10. Y-box binding proteins in immunity and RNA virus infection.Microbiology and molecular biology reviews : MMBR · 2025
    Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 4 institutions in 1 country.

Sarah E DremelDepartment of Microbiology and Molecular Genetics, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA.ORCID http://orcid.org/0000-0003-0968-3090
Frances L SivrichDepartment of Microbiology and Molecular Genetics, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA.
Jessica M TuckerDepartment of Plant and Microbial Biology, University of California Berkeley, Berkeley, CA, USA.
Britt A GlaunsingerDepartment of Plant and Microbial Biology, University of California Berkeley, Berkeley, CA, USA.ORCID http://orcid.org/0000-0003-0479-9377
Neal A DeLucaDepartment of Microbiology and Molecular Genetics, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA. ndeluca@pitt.edu.ORCID http://orcid.org/0000-0001-8381-8577
University of Pittsburgh · USHoward Hughes Medical Institute · USNational Institutes of Health · USUniversity of Iowa · US

Funding

Virus-cell Interactions Affecting HSV Gene ExpressionR01AI030612 · NIAID · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI Neal A. DeLuca · 1992 to 2026
$9.3M
Immunology of Infectious DiseaseT32AI060525 · NIAID · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI JoAnne L. Flynn · 2005 to 2026
$5.3M
Regulation of Gammaherpesviral Late Gene ExpressionR01AI122528 · NIAID · UNIVERSITY OF CALIFORNIA BERKELEY · PI Britt A Glaunsinger · 2016 to 2026
$4.2M
CLONING AND CHARACTERIZATION OF ADENOVIRUS RECEPTORSR01AI036251 · NIAID · BROOKHAVEN SCIENCE ASSOC-BROOKHAVEN LAB · PI FREIMUTH, PAUL I · 1996 to 2004
$1.5M
Modulation and Utilization of RNA Polymerase III by Herpes Simplex VirusR21AI156065 · NIAID · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI DELUCA, NEAL A. · 2021 to 2022
$432k
Functional Characterization of Herpesvirus-Activated Noncoding Retrotransposon RNAsR21AI147183 · NIAID · UNIVERSITY OF CALIFORNIA BERKELEY · PI GLAUNSINGER, BRITT A · 2019 to 2020
$423k
Howard Hughes Medical InstituteNIAID NIH HHS R01 AI030612NIAID NIH HHS R01 AI036251NIAID NIH HHS R01 AI122528NIAID NIH HHS R21 AI147183NIAID NIH HHS R21 AI156065NIAID NIH HHS T32 AI060525
6 · The paper itself

Abstract

RNA polymerase III (Pol III) transcribes noncoding RNA, including transfer RNA (tRNA), and is commonly targeted during cancer and viral infection. We find that Herpes Simplex Virus-1 (HSV-1) stimulates tRNA expression 10-fold. Perturbation of host tRNA synthesis requires nuclear viral entry, but not synthesis of specific viral transcripts. tRNA with a specific codon bias were not targeted-rather increased transcription was observed from euchromatic, actively transcribed loci. tRNA upregulation is linked to unique crosstalk between the Pol II and III transcriptional machinery. While viral infection results in depletion of Pol II on host mRNA promoters, we find that Pol II binding to tRNA loci increases. Finally, we report Pol III and associated factors bind the viral genome, which suggests a previously unrecognized role in HSV-1 gene expression. These findings provide insight into mechanisms by which HSV-1 alters the host nuclear environment, shifting key processes in favor of the pathogen.

Indexed as

Transcription FactorsGenome, ViralHerpesvirus 1, HumanHumansPromoter Regions, GeneticRNA, MessengerRNA Polymerase IIRNA Polymerase IIIRNA, TransferRNA, UntranslatedTranscriptional ActivationTranscription, GeneticVirus ReplicationRNA, MessengerRNA Polymerase IIRNA Polymerase IIIRNA, TransferRNA, UntranslatedTranscription Factors

Identifiers

PMID35110532
PMCPMC8810925
OpenAlexW4225571459

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.